DCAL
Dishman Carbogen Amcis Limited
NSELast Traded Price
₹151
1.99 (1.34%)
Open
₹150.1
High
₹151.41
Low
₹148
Prev Close
₹149.01
Industry
Pharmaceuticals
Market Cap
2360.53 Cr
Filing History
Recent corporate announcements and filings for DCAL
Routine
Neutral
2026-10-07 14:25
- Dishman Carbogen Amcis Limited's board approved issuing up to 3,800 senior, secured, rated, listed, redeemable, taxable non-convertible debentures (NCDs) aggregating up to Rs. 38 crores on a private placement basis.
- The NCDs carry a coupon of 10.00% p.a., with a tenure of 18 months (maturity on April 15, 2028), quarterly interest payments, and bullet repayment of principal.
- The board also approved modifying the security for its existing Rs. 15 crore NCDs (Tranche II, Scrip Code 978230) by substituting the promoter's land mortgage with a 100% cash margin via a lien-marked Fixed Deposit.
Routine
Neutral
2026-09-28 12:23
- Dishman Carbogen Amcis Limited has approved the allotment of 1,500 Senior, Secured, Rated, Listed, Redeemable, Transferable, Taxable Non-Convertible Debentures (NCDs) of face value ₹1,00,000 each on a private placement basis.
- Total aggregate amount raised is ₹15 Crores.
- Date of allotment is September 28, 2026, with maturity on March 28, 2028.
Routine
Neutral
2026-09-24 19:57
- Trading window for dealing in securities of the company shall remain closed starting from 1st October, 2026.
- Closure applies to all Directors, Designated Persons, and their immediate relatives.
- Trading window will reopen 48 hours after the announcement of un-audited financial results for the quarter and half year ending 30th September, 2026.